Your browser doesn't support javascript.
Cytoprotective action of renalase in diabetic kidney disease: an update on its association with cardiovascular disease and COVID -19
Biomedicine (India) ; 42(6):1114-1121, 2022.
Article in English | EMBASE | ID: covidwho-2206932
ABSTRACT
Renalase is a mono amine oxidase enzyme that can metabolise the active catecholamines in the body. Renalase is typically expressed in the cardiovascular system, skeletal muscle, and renal system. Renalase gene is important in human diseases and is known to break down catecholamines in the blood. Gene for renalase as extreme frequency of congestive heart failure disease in people with long term renal disease and other disorders was shown to be explained by a protein that is released by the kidney. Recent advances have increased our understanding of its structure, enzymatic activity, mechanisms of action, relationships with human disease states, and potential therapeutic value. An enzyme description of renalase is provided in this review, along with COVID-19 infection. Copyright © 2022, Indian Association of Biomedical Scientists. All rights reserved.
Keywords

Full text: Available Collection: Databases of international organizations Database: EMBASE Language: English Journal: Biomedicine (India) Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: EMBASE Language: English Journal: Biomedicine (India) Year: 2022 Document Type: Article